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Background
The aim of this study is to detect whether there is a sig-
nificant difference between patients receiving 100 mg
enteric coated salicylate before coronary artery surgery
with patients not receiving in terms of postoperative
mortality rates.
Methods
Sixty one patients that underwent coronary bypass sur-
gery between January 2011 and December 2011 at our
clinic were investigated retrospectively. Sixty one
(80.3%) of them were operated on under cardiopulmon-
ary bypass and 12 (19.7%) were operated on beating
heart. Thirty (49.2%) of them were receivers of 100 mg
enteric coated salicylate and 31 (50.8%) were non-recei-
vers, divided into 2 groups. The mean age of salicylate
receivers was 61.33 years whereas it was 57.71 years in
the non-receivers.
Results
The mortality rate was 4.5% for cases receiving salicylate
that underwent coronary surgery using cardiopulmonary
bypass (CPB), and 3.7% for cases not receiving salicylate.
No significant difference was seen (p>0.05). No mortal-
ity was seen among patients that underwent coronary
surgery on beating heart.
Conclusions
In this study, we investigated the patient groups that
underwent surgery in either method. Salicylate use did
not cause any increase in mortality rate with no signifi-
cant difference.
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